Delivery Order SPE2DB20D2014-SPE2DB25FB84L
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,768.44, is for the delivery of XCOPRI 150 MG TABLET 30S, a specialty pharmaceutical product. The contract does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,849.08, is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication XCOPRI 200 MG TABLET 30S. The contract has a ceiling value of $1,767.72 and is a firm fixed-price delivery order, with a period of performance through May 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,178.96, is for the supply of the specialty medication XCOPRI 200 MG TABLET 30S. It is a firm fixed-price contract with a completion date of December 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 200 MG TABLET 30S, a specialty pharmaceutical product, with a ceiling value of $2,357.92 and a completion date of November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,357.92, is for the delivery of the drug XCOPRI 100 MG TABLET 30S. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.20, is for the delivery of 4567957363 ! XCOPRI 100 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 18, 2025. This contract is not a set-aside and is an open competition award. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4568076802 - XCOPRI 200 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $3,536.88 and a period of performance ending on April 30, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a ceiling value of $3,257.73 and a performance period through March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,768.44 and covers the delivery of the prescription medication XCOPRI 150 MG TABLET 30S. The contract has an ultimate completion date of May 2, 2025. This contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a...